Visualization of alternative Epstein-Barr virus expression programs by fluorescent in situ hybridization at the cell level

Journal of Virology

Volumn 73, Issue 6, 1999, Pages 5064-5069

  Szeles, Anna ^a   Falk, Kerstin I ^a   Imreh, Stephan ^a   Klein, George ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOBLAST; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS CELL TRANSFORMATION; VIRUS EXPRESSION; VIRUS TRANSCRIPTION;

EID: 0033060756     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.6.5064-5069.1999     Document Type: Article

References (35)

1. Arrand, J. R., L. Rymo, J. L. Walsh, E. Bjorck, T. Lindhal, and B. E. Griffin. 1981. Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments. Nucleic Acids Res. 9: 2999-3014.
2. Carter, K. C., and J. B. Lawrence. 1991. DNA and RNA within the nucleus: how much sequence-specific spatial organization? J. Cell. Biochem. 47:124-129.
3. Chen, F., J. Z. Zou, L. di Renzo, G. Winberg, L. F. Hu, E. Klein, G. Klein, and I. Ernberg. 1995. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-I but not EBNA-2 or LMP1. J. Virol. 69:3752-3758.
4. Dirks, R. W., K. C. Daniel, and A. K. Raap. 1995. RNAs radiate from gene to cytoplasm as revealed by fluorescence in situ hybridization. J. Cell Sci. 108: 2565-2572.
5. Fåhraeus, R., H. L. Fu, I. Ernberg, J. Finke, M. Rowe, G. Klein, K. Falk, E. Nilsson, M. Yadav, P. Busson, T. Tursz, and B. Kallin. 1988. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int. J. Cancer 42:329-338.
6. Gargano, S., D. Caporossi, G. Gualandi, and E. Calef. 1992. Different localization of Epstein-Barr virus genome in two subclones of the Burkitt lymphoma cell line Namalwa. Genes Chromosome Cancer 4:205-210.
7. Gregory, C. D., M. Rowe, and A. B. Rickinson. 1990. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J. Gen. Virol. 71:1481-1495.
8. Henderson, A., S. Ripley, M. Heller, and E. Kieff. 1983. Chromosome site for Epstein Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro. Proc. Natl. Acad. Sci. USA 80:1987-1991.
9. + malignant lymphomas. Crit. Rev. Oncol. Hematol. 4:191-239.
10. Huang, S., and D. L. Spector. 1991. Nascent pre-mRNA transcripts are associated with nuclear regions enriched in splicing factors. Genes Dev. 5: 2288-2302.
11. Hurley, E. A., L. D. Klaman, S. Agger, J. B. Lawrence, and D. A. Thorley-Lawson. 1991. The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but not episomal viral DNA. J. Virol. 65:3958-3963.
12. Kieff, E. 1996. Epstein-Barr virus and its replication, p. 2343-2396. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Month, B. Roizman, and S. E. Straus (ed.), Fields virology. Lippincott-Raven, Philadelphia, Pa.
13. King, W., A. L. Thomas-Powell, N. Raah-Traub, M. Hawke, and E. Kieff. 1980. Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell. J. Virol. 36:506-518.
14. Klein, G. 1994. Epstein-Barr virus strategy in normal and neoplastic B cells Cell 77:791-793.
15. Klein, G., L. Dombos, and B. Gothoskar. 1972. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus. Int. J. Cancer 10:44-57.
16. Lawrence, J. B., K. C. Carter, and X. Xing. 1993. Probing functional organization within the nucleus: is genome structure integrated with RNA metabolism? Cold Spring Harbor Symp. Quant. Biol. 58:807-818.
17. Lawrence, J. B., R. H. Singer, and L. M. Marselle. 1989. Highly localized tracks of specific transcripts within interphase nuclei visualized by in situ hybridization. Cell 57:493-502.
18. Lenoir, G. M., M. Vuillaume, and C. Bonnardel. 1985. The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. IARC (Int. Agency Res. Cancer) Sci. Publ. 60:309-318.
19. Lestou, V. S., S. Strehl, T. Lion, H. Gadner, and P. F. Ambros. 1996. High-resolution FISH of the entire integrated Epstein-Barr virus genome on extended human DNA. Cytogenet. Cell Genet. 74:211-217.
20. Levitskaya, J., M. Coram, V. Levitsky, S. Imreh, P. M. Steigerwald-Mullen, G. Klein, M. G. Kurilla, and M. G. Masucci. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685-688.
21. Masucci, M. G., and I. Ernberg. 1994. Epstein-Barr virus: adaptation to a life within the immune system. Trends Microbiol. 2:125-130.
22. Masucci, M. G., B. Contreras-Salazar, E. Ragnar, K. Falk, J. Minarovits, I. Ernberg, and G. Klein. 1989. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line Rael. J. Virol. 63:3135-3141.
23. Pallesen, G., S. J. Hamilton-Dutoit, and X. Zhou. 1993. The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: two new developments in the EBV field. Adv. Cancer Res. 62:179-239.
24. Pinkel, D., T. Straume, and J. W. Gray. 1986. Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc. Natl. Acad. Sci. USA 83:2934-2938.
25. Raap, A. K., F. M. van de'Rijke, R. W. Dirks, C. J. Sol, R. Boom, and M. van der Ploeg. 1991. Bicolor fluorescence in situ hybridization to intron and exon mRNA sequences. Exp. Cell Res. 197:319-322.
26. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2476. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Month, B. Roizman, and S. E. Straus (ed.), Fields virology. Lippincott-Raven, Philadelphia, Pa.
27. Rosbash, M., and R. H. Singer. 1993. RNA travel: tracks from DNA to cytoplasm. Cell 75:399-401.
28. Rowe, M., D. T. Rowe, C. D. Gregory, L. S. Young, P. J. Farrell, H. Rupani, and A. B. Rickinson. 1987. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burrkitt's lymphoma cells. EMBO J. 6:2743-2751.
29. Schaefer, B. C., J. L. Strominger, and S. H. Speck. 1995. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc. Natl. Acad. Sci. USA 92:10565-10569.
30. Spector, D. L. 1993. Nuclear organization of pre-mRNA processing. Curr. Opin. Cell Biol. 5:442-447.
31. Székely, L. Unpublished data.
32. Szeles, A., S. Bajalica, A. Lindblom, T. Lushnikova, V. I. Kashuba, S. Imreh, M. Nordenskjöld, G. Klein, and E. R. Zabarovsky. 1996. Mapping of a new MAP kinase activated protein kinase gene (3pK) to human chromosome band 3p21.2 and ordering of 3pK and two cosmid markers in 3p22-p21 tumor suppressor region by two color FISH. Chromosome Res. 4:310-313.
33. Xing, Y., and J. B. Lawrence. 1991. Preservation of specific RNA distribution within the chromatin-depleted nuclear substructure demonstrated by in situ hybridization coupled with biochemical fractionation. J. Cell Biol. 112:1055-1063.
34. Xing, Y., and J. B. Lawrence. 1993. Nuclear RNA tracks: structural basis for transcription and splicing? Trends Cell Biol. 3:346-353.
35. Xing, Y., C. V. Johnson, P. R. Dobner, and J. B. Lawrence. 1993. Higher level organization of individual gene transcription and RNA splicing. Science 259: 1326-1330.